# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | 5-Ethynyluracil | 4a | inhibition | = | -0.07 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
2. | 5-Ethynyluracil | 4a | inhibition | = | -0.05 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
3. | 5-Ethynyluracil | 4a | inhibition | = | 0.27 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
4. | 5-Ethynyluracil | 4a | Inhibition | = | 8.092 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
5. | 5-Ethynyluracil | 4a | Inhibition | = | 5.91 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
6. | 5-Ethynyluracil | 4a | Inhibition | = | 27.89 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
7. | 5-Ethynyluracil | 4a | inhibition | = | -0.05 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
8. | 5-Ethynyluracil | 4a | inhibition | = | 0.27 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
9. | 5-Ethynyluracil | 4a | inhibition | = | -0.07 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
10. | 5-Ethynyluracil | 4a | inhibition | = | -9.6 | % | ALA4808150 | % | Homo sapiens | |||
11. | 5-Ethynyluracil | 4a | inhibition | = | -6.92 | % | ALA4808149 | % | Homo sapiens | |||
12. | 5-Ethynyluracil | 4a | Inhibition | = | -0.06 | % | ALA4303805 | % | Severe acute respiratory syndrome coronavirus 2 | |||
13. | 5-Ethynyluracil | 4a | Kinact | = | 5.64 | /min | ALA4617528 | /min | Bos taurus | |||
14. | 5-Ethynyluracil | 4a | IC50 | = | 0.014 | uM | ALA665825 | 7.85 | nM | Homo sapiens |